You can:
Name | Somatostatin receptor type 1 |
---|---|
Species | Homo sapiens (Human) |
Gene | SSTR1 |
Synonym | SRIF-2 SS-1-R SS1-R SS1R SST1 receptor |
Disease | Alzheimer disease Cushing's disease Neuroendocrine cancer |
Length | 391 |
Amino acid sequence | MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL |
UniProt | P30872 |
Protein Data Bank | N/A |
GPCR-HGmod model | P30872 |
3D structure model | This predicted structure model is from GPCR-EXP P30872. |
BioLiP | N/A |
Therapeutic Target Database | T16633 |
ChEMBL | CHEMBL1917 |
IUPHAR | 355 |
DrugBank | BE0000452 |
Name | SOMATOSTATIN |
---|---|
Molecular formula | C76H104N18O19S2 |
IUPAC name | (4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid |
Molecular weight | 1637.9 |
Hydrogen bond acceptor | 24 |
Hydrogen bond donor | 22 |
XlogP | -3.1 |
Synonyms | Somatostatin, cyclic Somatostatinum [INN-Latin] UNII-F6R2N217HS 6E20216Q0L C76H104N18O19S2 [ Show all ] |
Inchi Key | NHXLMOGPVYXJNR-ATOGVRKGSA-N |
Inchi ID | InChI=1S/C76H104N18O19S2/c1-41(79)64(100)82-37-61(99)83-58-39-114-115-40-59(76(112)113)92-72(108)57(38-95)91-75(111)63(43(3)97)94-71(107)54(33-46-23-11-6-12-24-46)90-74(110)62(42(2)96)93-66(102)51(28-16-18-30-78)84-69(105)55(34-47-36-81-49-26-14-13-25-48(47)49)88-68(104)53(32-45-21-9-5-10-22-45)86-67(103)52(31-44-19-7-4-8-20-44)87-70(106)56(35-60(80)98)89-65(101)50(85-73(58)109)27-15-17-29-77/h4-14,19-26,36,41-43,50-59,62-63,81,95-97H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t41-,42+,43+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,62-,63-/m0/s1 |
PubChem CID | 16129706 |
ChEMBL | CHEMBL1823872 |
IUPHAR | N/A |
BindingDB | 81767 |
DrugBank | DB09099 |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
IC50 | 0.14 nM | PMID23582449 | ChEMBL |
IC50 | 1.6 nM | PMID21806016 | BindingDB,ChEMBL |
IC50 | 1.9 nM | PMID24378707, PMID15658865 | ChEMBL |
Ki | 0.1 nM | PMID7870182 | BindingDB |
Ki | 0.1 nM | PMID8100350, PMID10433861 | BindingDB |
Ki | 0.29 nM | PMID11520208 | ChEMBL |
Ki | 0.36 nM | PMID11327607 | ChEMBL |
Ki | 0.36 nM | PMID11327607 | BindingDB |
Ki | 0.38 nM | PMID9724791, PMID12477342 | BindingDB,ChEMBL |
Ki | 0.43 nM | PMID24342240 | ChEMBL |
Ki | 0.56 nM | PMID10818260 | BindingDB |
Ki | 0.63 nM | PMID9290757 | BindingDB |
Ki | 0.631 nM | PMID12773038 | ChEMBL |
Ki | 0.75 nM | PMID10598788 | BindingDB |
Ki | 0.76 nM | PMID9650799 | BindingDB |
Ki | 0.83 nM | PMID10598788, PMID9650799 | BindingDB |
Ki | 1.1 nM | PMID7988476 | BindingDB |
Ki | 1.12 nM | PMID10598788 | BindingDB |
Ki | 2.1 nM | PMID1328199 | BindingDB |
Ki | 2.25 nM | PMID9600011 | BindingDB |
Ki | 2.3 nM | PMID16220980 | ChEMBL |
pKD | 9.08 - | PMID11448228 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417